Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
CRMP3 Blocking Peptide (AC1358)
Cat.#: ACPP-1358
Specifications
Despition CRMP3 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1389 AHSG (AC1389) 10 µg inquiry ACPP-1345 DISC1 Blocking Peptide (AC1345) 250 µg inquiry ACPP-1699 Human Human Prealbumin (Active) Protein (AC1699) 1 mg inquiry ACPP-1480 Human FKBP1B Protein (AC1480) 5 µg inquiry ACPP-1456 Human HEXA Protein (AC1456) 5 µg inquiry ACPP-1769 Human VAT1 Protein (AC1769) 2 µg inquiry ACPP-1568 Human NME4 Protein (AC1568) 5 µg inquiry ACPP-1844 Human GCLM Protein (AC1844) 5 µg inquiry ACPP-1754 Human VEGFC Protein, Sf9 (AC1754) 2 µg inquiry ACPP-1202 Pin1 Blocking Peptide (AC1202) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket